Medical specialists from Canada tagged as investigators in clinical trials studying Carcinoma, Adenosquamous
Total 11 results
-
Christina KimSeen in:
- Manitoba, Winnipeg, CancerCare Manitoba
Trials:- NCT04340141 (Principal Investigator)
-
Daniel J. RenoufSeen in:
- British Columbia, Vancouver, BCCA-Vancouver Cancer Centre
Trials:- NCT04340141 (Principal Investigator)
-
Frederic LemaySeen in:
- Quebec, Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
- Quebec, Sherbrooke, GSK Investigational Site
Trials:- NCT04068103 (Principal Investigator)
- NCT04340141 (Principal Investigator)
- NCT05723562 (Principal Investigator)
-
George ZogopoulosSeen in:
- Quebec, Montreal, McGill University Health Centre
- Quebec, Montreal, The Research Institute of the McGill University Health Centre (MUHC)
Trials:- NCT04970056 (Principal Investigator)
- NCT04340141 (Principal Investigator)
-
Guillaume MartelSeen in:
- Ontario, Ottawa, Ottawa Hospital and Cancer Center-General Campus
Trials:- NCT04340141 (Principal Investigator)
-
Jean-Francois OuelletSeen in:
- Quebec, Quebec City, CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
Trials:- NCT04340141 (Principal Investigator)
-
Michael J. RaphaelSeen in:
- Ontario, Toronto, Odette Cancer Centre- Sunnybrook Health Sciences Centre
Trials:- NCT04340141 (Principal Investigator)
-
Nicholas A. BosmaSeen in:
- British Columbia, Victoria, BCCA-Vancouver Island Cancer Centre
Trials:- NCT04340141 (Principal Investigator)
-
Pablo E. SerranoSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre at Hamilton Health Sciences
Trials:- NCT04239573 (Principal Investigator)
- NCT04340141 (Principal Investigator)
-
Patricia TangSeen in:
- Alberta, Calgary, Tom Baker Cancer Centre
Trials:- NCT04068103 (Principal Investigator)
- NCT04340141 (Principal Investigator)
-
Ravi A. RamjeesinghSeen in:
- Nova Scotia, Halifax, QEII Health Sciences Centre/Nova Scotia Health Authority
Trials:- NCT04340141 (Principal Investigator)
Clinical Trials on Carcinoma, Adenosquamous
-
Shanghai Henlius BiotechRecruitingESCC or Esophageal Adenosquamous CarcinomaChina
-
Fujian Cancer HospitalJiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
Eurofarma Laboratorios S.A.WithdrawnAdenocarcinoma | Carcinoma | Uterine Cervix Adenosquamous CarcinomaBrazil
-
UNC Lineberger Comprehensive Cancer CenterCompletedCervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Cervix CarcinomaUnited States
-
Western Regional Medical CenterTerminatedAdenocarcinoma of the Cervix | Adenosquamous Cell Carcinoma of the CervixUnited States
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell Carcinoma | Pancreatic Adenosquamous Carcinoma | Pancreatic Squamous Cell Carcinoma | Resectable Pancreatic Acinar Cell Carcinoma | Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Recurrent Cervical CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
Dana-Farber Cancer InstituteCelgene CorporationTerminatedSquamous Cell Carcinoma of the Head and Neck | Basaloid Squamous Cell Carcinoma | Undifferentiated Carcinoma | Adenosquamous Cell Carcinoma
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Advaxis, Inc.CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical CarcinomaUnited States